IN2014MU00328A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00328A
IN2014MU00328A IN328MU2014A IN2014MU00328A IN 2014MU00328 A IN2014MU00328 A IN 2014MU00328A IN 328MU2014 A IN328MU2014 A IN 328MU2014A IN 2014MU00328 A IN2014MU00328 A IN 2014MU00328A
Authority
IN
India
Prior art keywords
drug
dissolution
nanocrystal
bioavailability
crystallized
Prior art date
Application number
Other languages
English (en)
Inventor
Kumar Guntamukkala Santosh
Satyanarayan Pattnaik
Kalpana Swain
Venkateshwar Rao Jupally
Baikuntha Prusty Korada
Sanjeev Kumar Subudhi
Original Assignee
Kumar Guntamukkala Santosh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kumar Guntamukkala Santosh filed Critical Kumar Guntamukkala Santosh
Priority to IN328MU2014 priority Critical patent/IN2014MU00328A/en
Publication of IN2014MU00328A publication Critical patent/IN2014MU00328A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN328MU2014 2014-01-30 2014-01-30 IN2014MU00328A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN328MU2014 IN2014MU00328A (es) 2014-01-30 2014-01-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN328MU2014 IN2014MU00328A (es) 2014-01-30 2014-01-30

Publications (1)

Publication Number Publication Date
IN2014MU00328A true IN2014MU00328A (es) 2015-09-11

Family

ID=54393678

Family Applications (1)

Application Number Title Priority Date Filing Date
IN328MU2014 IN2014MU00328A (es) 2014-01-30 2014-01-30

Country Status (1)

Country Link
IN (1) IN2014MU00328A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021008652A1 (de) * 2019-07-15 2021-01-21 MyBiotech GmbH Nanostrukturierte ibuprofen-zusammensetzungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021008652A1 (de) * 2019-07-15 2021-01-21 MyBiotech GmbH Nanostrukturierte ibuprofen-zusammensetzungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzung

Similar Documents

Publication Publication Date Title
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
PH12016502378A1 (en) Substituted dihydroisoquinolinone compounds
MX2016001023A (es) Formulaciones que contienen dapagliflozina amorfa.
MX2015010856A (es) Derivados de 2-aminopirimidina para el tratamiento de infecciones viricas.
PH12016501122A1 (en) Delayed release compositions of linaclotide
MX355330B (es) Formas cristalinas de compuestos terapeuticos y sus usos.
PH12017502155A1 (en) Formation of cyclosporin a/cyclodextrin nanoparticles
WO2016011049A3 (en) Compositions and methods for disease treatment using nanoparticle delivered compounds
MY190283A (en) Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
WO2014131422A3 (en) Fermented rapeseed feed ingredient
NZ704092A (en) Ph adjusted pulse protein product
MX2016011358A (es) Composiciones liquidas de lactasa.
MX370488B (es) Prevencion de infecciones por staphylococcus aureus mediante vacunas de glucoproteina sintetizadas en escherichia coli.
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
WO2016199076A3 (en) Polymorphic forms of afatinib free base and afatinib dimaleate
SG10201909412RA (en) Composition for suppressing muscular fatty change
MX357888B (es) Sales basicas de adicion de nitroxolina y usos de las mismas.
IN2014MU00328A (es)
PH12015502820A1 (en) Nanoparticulate formulation comprising a trpa1 antagonist
SG10201902499VA (en) Therapeutic nanoparticles and related compositions, methods and systems
WO2015074667A3 (en) Composition for dermatitis
NZ728136A (en) Method for producing aqueous ophthalmic composition, and aqueous ophthalmic composition
IN2013MU03610A (es)
IN2013CH04330A (es)
PL407710A1 (pl) Sposób wytwarzania preparatu kropli do oczu w postaci zawiesiny zawierającej brynzolamid i preparat wytworzony tym sposobem